Provided by Tiger Trade Technology Pte. Ltd.

Bristol-Myers Squibb

58.94
+1.552.70%
Pre-market: 58.78-0.1600-0.27%07:03 EDT
Volume:9.05M
Turnover:532.80M
Market Cap:119.99B
PE:17.03
High:59.39
Open:57.79
Low:57.79
Close:57.39
52wk High:62.89
52wk Low:42.52
Shares:2.04B
Float Shares:2.03B
Volume Ratio:0.40
T/O Rate:0.45%
Dividend:2.49
Dividend Rate:4.23%
EPS(TTM):3.46
EPS(LYR):3.46
ROE:40.44%
ROA:10.29%
PB:6.50
PE(LYR):17.03

Loading ...

BRIEF-Bristol Myers Squibb Launches Campaign With Johnson & Johnson

Reuters
·
Feb 03

BRIEF-Opdivo Plus Yervoy Reimbursed Under Ontario's Fast Program As First-Line Treatment For Advanced Liver Cancer

Reuters
·
Feb 03

Opdivo® Plus Yervoy® Reimbursed Under Ontario's Fast Program as First-Line Treatment for Advanced Liver Cancer

THOMSON REUTERS
·
Feb 03

Bristol Myers Squibb startet Zusammenarbeit mit Johnson & Johnson zur Entwicklung neuer Thrombose-Therapien

Reuters
·
Feb 03

Bristol Myers Squibb Introduces "Change the Target. Change What’s Possible.” to Highlight Unmet Needs in Cardiovascular and Thromboembolic Care

THOMSON REUTERS
·
Feb 03

Analysts Offer Insights on Healthcare Companies: Bristol-Myers Squibb (BMY) and Regeneron (REGN)

TIPRANKS
·
Feb 03

Bristol Myers Squibb Co. Stock Underperforms Monday When Compared To Competitors Despite Daily Gains

Dow Jones
·
Feb 03

Bristol-Myers Squibb Cancer And AI Deals Put Valuation In Focus

Simply Wall St.
·
Jan 31

Preview -- Barron's

Dow Jones
·
Jan 31

BioNTech and Bristol-Myers Squibb Advance Pumitamig Trial in Aggressive Brain Cancer

TIPRANKS
·
Jan 31

Moderna CMO Jacqueline Miller to step down

Reuters
·
Jan 30

A Look At Bristol Myers Squibb (BMY) Valuation After Recent Share Price Momentum

Simply Wall St.
·
Jan 30

Bristol-Myers Squibb Expands Real-World Evidence for Mavacamten in China: What Investors Should Know

TIPRANKS
·
Jan 30

Earning Preview: Bristol-Myers Squibb Q4 revenue is expected to increase by 5.96%, and institutional views are cautiously bullish

Earnings Agent
·
Jan 29

Piper Sandler Adjusts Bristol-Myers Squibb Price Target to $66 From $62, Maintains Overweight Rating

MT Newswires Live
·
Jan 28

BUZZ-U.S. STOCKS ON THE MOVE-Archer-Daniels-Midland, Danaher, Brinker International

Reuters
·
Jan 28

Medicare is about to start negotiating the prices of medications administered by doctors

Dow Jones
·
Jan 28

BUZZ-U.S. STOCKS ON THE MOVE-Texas Instruments, Seagate, Nextpower

Reuters
·
Jan 28

U.S. RESEARCH ROUNDUP- Boeing, Carvana, UnitedHealth

Reuters
·
Jan 28

Bloomsbury Opens Singapore Hub to Target Surging Asian Academic Market

TIPRANKS
·
Jan 28